These results suggested that TCF7L2 may directly regulate genes associated with BD risk and BMI or metabolic phenotypes in astrocytes, a possible molecular mechanism related to the role of TCF7L2 in the comorbidity of BD and obesity. Here, TCF7L2 is linked to obesity due to melanocortin 4 receptor deficiency.